Evidence map›Paper›PMID 28174340›Full record

ArticleThorax2017

Genetic variants affecting cross-sectional lung function in adults show little or no effect on longitudinal lung function decline.

Catherine John, María Soler Artigas, Jennie Hui, Sune Fallgaard Nielsen, Nicholas Rafaels, Peter D Paré, Nadia N Hansel, Nick Shrine, Iain Kilty, Anders Malarstig and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Towards early detection and disease interception of COPD across the lifespan.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. On Genetics, Lung Developmental Biology, and Adult Lung Function.American journal of respiratory and critical care medicine · 2020
    Article
  12. Lung Development Genes and Adult Lung Function.American journal of respiratory and critical care medicine · 2020
    Article
  13. Article
  14. Article
  15. Genetics of COPD.Annual review of physiology · 2020
    Review
  16. Lung functional development and asthma trajectories.Seminars in immunopathology · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 6 countries.

Catherine JohnGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.ORCID 0000-0002-6057-2073
María Soler ArtigasGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Jennie HuiSchool of Pathology and Laboratory Medicine, The University of Western Australia, Australia.
Sune Fallgaard NielsenDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark.
Nicholas RafaelsCenter for Personalized Medicine and Biomedical Informatics, School of Medicine, University of Colorado, Anschutz Medical Campus.
Peter D ParéUniversity of British Columbia Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, British Columbia, Canada.
Nadia N HanselDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Nick ShrineGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Iain KiltyPfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
Anders MalarstigPfizer Worldwide Research and Development, Stockholm, Sweden.
Scott A JelinskyPfizer Worldwide Research and Development, Cambridge, Massachusetts, USA.
Signe Vedel-KroghDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark.
Kathleen BarnesCenter for Personalized Medicine and Biomedical Informatics, School of Medicine, University of Colorado, Anschutz Medical Campus.
Ian P HallDivision of Respiratory Medicine, Queen's Medical Centre, University of Nottingham, Nottingham, UK.
John BeilbySchool of Pathology and Laboratory Medicine, The University of Western Australia, Australia.
Arthur W MuskBusselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Western Australia, Australia.
Børge G NordestgaardDepartment of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark.
Alan JamesBusselton Population Medical Research Institute, Sir Charles Gairdner Hospital, Western Australia, Australia.
Louise V WainGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
Martin D TobinGenetic Epidemiology Group, Department of Health Sciences, University of Leicester, Leicester, UK.
University of Leicester · GBThe University of Western Australia · AUGentofte Hospital · DKPfizer (United States) · USUniversity of Colorado Anschutz Medical Campus · USJohns Hopkins University · USPfizer (Sweden) · SEUniversity of British Columbia · CAUniversity of Nottingham · GB

Funding

Genome-Wide Associations Environmental Interactions in the Lung Health StudyU01HG004738 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI BARNES, KATHLEEN C · 2008 to 2009
$1.2M
EARLY INTERVENTION/CHRONIC OBSTRUCTIVE PULMONARY DISEASEN01HR046002 · HR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CONNETT, JOHN E · 1985 to 1998
–
Medical Research Council G0902313Medical Research Council G1000861Medical Research Council MC_PC_12010Medical Research Council MR/N011317/1Medical Research Council MR/P00167X/1NHGRI NIH HHS U01 HG004738NHLBI NIH HHS N01 HR046002Wellcome Trust 202849/Z/16/Z
6 · The paper itself

Abstract

backgroundGenome-wide association studies have identified numerous genetic regions that influence cross-sectional lung function. Longitudinal decline in lung function also includes a heritable component but the genetic determinants have yet to be defined.

objectivesWe aimed to determine whether regions associated with cross-sectional lung function were also associated with longitudinal decline and to seek novel variants which influence decline.

methodsWe analysed genome-wide data from 4167 individuals from the Busselton Health Study cohort, who had undergone spirometry (12 695 observations across eight time points). A mixed model was fitted and weighted risk scores were calculated for the joint effect of 26 known regions on baseline and longitudinal changes in FEV

resultsThe 26 regions previously associated with cross-sectional lung function jointly showed a strong effect on baseline lung function (p=4.44×10

conclusionsPreviously identified genetic variants jointly have a strong effect on cross-sectional lung function in adults but little or no effect on the rate of decline of lung function. It is possible that they influence COPD risk through lung development. Although no genetic variants have yet been associated with lung function decline at stringent genome-wide significance, longitudinal change in lung function is heritable suggesting that there is scope for future discoveries.

Indexed as

Genetic VariationAdultCross-Sectional StudiesDisease ProgressionFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansLongitudinal StudiesMaleMiddle AgedPulmonary Disease, Chronic ObstructiveRespirationRespiratory Function TestsRisk AssessmentCOPD ÀÜ MechanismsCOPD epidemiologyLung PhysiologyRespiratory Measurement

Identifiers

PMID28174340
PMCPMC5520280
OpenAlexW2580815378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.